METHOD FOR TREATMENT OF DIABETIC RETINOPATHY WITH NATURALLY OCCURRING INSULIN-LIKE GROWTH FACTORS (IGFS) AND IGF ANALOGS

Details for Australian Patent Application No. 2002245333 (hide)

Owner COLORADO STATE UNIVERSITY RESEARCH FOUNDATION

Inventors ISHII, Douglas, N.

Pub. Number AU-A-2002245333

PCT Pub. Number WO2002/060473

Priority 60/265,803 31.01.01 US

Filing date 29 January 2002

Wipo publication date 12 August 2002

International Classifications

A61K 038/30 Medicinal preparations containing peptides - Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2

A61P 027/02 Drugs for disorders of the senses

A61P 037/00 Drugs for immunological or allergic disorders

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-A-2002245333

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002245334-HIGH RESOLUTION ETALON-GRATING MONOCHROMATOR SPECTROMETER

2002245332-ANERGY-REGULATED MOLECULES